FK 506 and Rapamycin in Combination Are Not Antagonistic but Produce Extended Small Bowel Graft Survival in the Mouse

This publication has 14 references indexed in Scilit:

• THE IMMUNOSUPPRESSIVE EFFECT OF RAPAMYCIN ON MOUSE SMALL BOWEL TRANSPLANTATION1
  Transplantation, 1996
• Rapamycin (sirolimus, rapamune)
  Current Opinion in Nephrology and Hypertension, 1995
• REVERSAL OF ONGOING HEART, KIDNEY, AND PANCREAS ALLOGRAFT REJECTION AND SUPPRESSION OF ACCELERATED HEART ALLOGRAFT REJECTION IN THE RAT BY RAPAMYCIN
  Transplantation, 1993
• The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
  The Journal of Experimental Medicine, 1992
• Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal Transduction
  Annual Review of Immunology, 1992
• THE EFFECT OF RAPAMYCIN ON KIDNEY FUNCTION IN THE SPRAGUE-DAWLEY RAT
  Transplantation, 1992
• FK506 and rapamycin: novel pharmacological probes of the immune response
  Trends in Pharmacological Sciences, 1991
• RAPAMYCIN, A POTENT IMMUNOSUPPRESSIVE DRUG FOR VASCULARIZED HEART, KIDNEY, AND SMALL BOWEL TRANSPLANTATION IN THE RAT
  Transplantation, 1991
• RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTING
  The Lancet, 1989
• FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.
  The Journal of Antibiotics, 1987